Welcome to our dedicated page for ASSURE HLDGS news (Ticker: IONM), a resource for investors and traders seeking the latest updates and insights on ASSURE HLDGS stock.
Assure Holdings Corp. (NASDAQ: IONM) is a leading provider of intraoperative neuromonitoring (IONM) and remote neurology services, based in Denver, Colorado. The company collaborates with neurosurgeons and orthopedic spine surgeons to offer a comprehensive suite of services that ensure the safety and integrity of the nervous system during invasive surgical procedures.
Assure Holdings employs a skilled team of technologists and utilizes state-of-the-art monitoring equipment to provide real-time feedback to surgeons during operations. Their services are crucial in procedures where the nervous system is at risk, including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. By managing 100% of the intraoperative neuromonitoring scheduling and setup, Assure ensures seamless integration into the surgical workflow.
The company is accredited by The Joint Commission, underscoring its commitment to delivering exceptional surgical care and a positive patient experience. Assure's mission revolves around a patient-driven focus, ensuring the highest quality service in the industry.
In recent developments, Assure Holdings has expanded its authorized shares from 9,000,000 to 250,000,000, enabling the company to raise capital and execute its strategic plans. Additionally, Assure is set to complete a significant transaction with Danam Health Inc., which will further bolster its market position and operational capabilities. The company has been granted an extension by the Nasdaq Listing Qualifications Panel to regain compliance with the continued listing requirements by July 22, 2024.
For more information, visit the company’s website at www.assureneuromonitoring.com.
Assure Holdings Corp. (NASDAQ: IONM) has successfully closed an underwritten public offering, generating approximately $6.2 million in gross proceeds by selling 5,576,087 shares at $1.12 per share. The funds will be used for general corporate purposes, including debt repayment and increasing working capital. Additionally, the underwriter has a 45-day option to buy more shares, potentially raising total proceeds to $7.2 million. This offering follows an effective shelf registration statement declared on August 17, 2022.
Assure Holdings Corp. (NASDAQ: IONM) appointed Robynn Sweet as vice president of strategic accounts, aiming to enhance business development opportunities with Group Purchasing Organizations (GPOs). Sweet brings over 12 years of expertise from her previous roles at Premier and HealthTrust, significantly contributing to revenue growth. This strategic hire aligns with Assure's focus on GPO and facilities-based contracts to bolster its presence in the intraoperative neuromonitoring sector, enhancing patient safety and clinical outcomes.
Assure Holdings Corp. (NASDAQ: IONM) has announced a public offering with expected gross proceeds of approximately $6.2 million, priced at $1.12 per share for 5,576,087 shares. The funds will be allocated for general corporate purposes, including debt repayment and working capital. Aegis Capital Corp. is managing the offering, which closes on August 24, 2022. An option for underwriters to purchase an additional 15% of shares could increase proceeds to $7.2 million. This offering follows an effective registration with the SEC.
Assure Holdings Corp. (NASDAQ: IONM) announced plans for a public offering of its common stock, aiming to use the proceeds for general corporate purposes including working capital. The offering is subject to market conditions, and no assurances are provided regarding its completion or terms. Aegis Capital Corp. is the sole book-running manager for the offering, which will be conducted under an effective shelf registration statement with the SEC. Investors are advised to review the accompanying prospectus and related documents for more details.
Assure Holdings Corp. (NASDAQ: IONM) reported a second quarter 2022 managed case volume increase of 36% year-over-year, reaching 5,800 cases. Gross revenue stood at $9.2 million, but net revenue fell to $1.6 million. A significant accounts receivable reserve of $7.6 million impacted net revenue and gross profit declined, resulting in an Adjusted EBITDA loss of $5.9 million. Despite these challenges, Assure expects a stronger second half of 2022 with continued managed case volume growth and a forecast of positive Adjusted EBITDA, aiming for over $22 million in gross revenue in the second half.
Assure Holdings Corp. (NASDAQ: IONM) announces its participation in the Sidoti Micro-Cap Virtual Conference, scheduled for August 18, 2022. John Farlinger, executive chairman and CEO, will present at 12:15 p.m. ET, while management will hold virtual one-on-one meetings with investors on August 17-18, 2022. Assure specializes in intraoperative neuromonitoring and remote neurology services, supporting surgeons in critical procedures to ensure patient safety. For more details and to register, visit here.
Assure Holdings Corp. (NASDAQ: IONM) will host a conference call on August 15, 2022, at 4:30 p.m. ET to discuss its second-quarter financial results for the period ending June 30, 2022. Interested parties can access the live webcast and presentation slides on the company’s investor relations page. An audio-only option is also available. The conference call replay will be accessible after 7:30 p.m. ET on the same day until August 29, 2022. Assure provides intraoperative neuromonitoring and remote neurology services, helping to ensure the safety of patients during surgical procedures.
Assure Holdings Corp. (NASDAQ: IONM), a provider of intraoperative neuromonitoring and remote neurology services, announced plans to streamline operations aiming for positive operating cash flow. The strategy includes cash-saving measures expected to yield $4 million annually through workforce reductions and expense cuts. Assure is focusing on profitable markets, enhancing managed care functions, and entering new markets with strong profitability prospects. CEO John A. Farlinger emphasized a defensive approach in 2022, managing costs to ensure future profitability while aiming for a record 25,000 managed cases.
Assure Holdings Corp. (NASDAQ: IONM), a provider of intraoperative neuromonitoring and remote neurology services, has engaged Hayden IR, LLC to enhance its presence in the investment community. CEO John A. Farlinger highlighted the partnership's aim to expand outreach and communicate business growth. Hayden IR’s Managing Partner, Brett Maas, expressed enthusiasm for introducing Assure to their network while supporting their telehealth services. The company, accredited by The Joint Commission, offers clinical and operational services for various invasive surgeries, ensuring real-time monitoring of patients' neural structures.
Assure Holdings Corp. (NASDAQ: IONM) will present at the Gravitas Securities Los Angeles Summit on June 23, 2022, at 1:00 p.m. ET. John Farlinger, the executive chairman and CEO, will lead the presentation, while management will also hold one-on-one meetings with investors from June 21-23, 2022. The summit will showcase numerous public and private companies, targeting venture capital and institutional investors from the U.S. and Canada. Assure specializes in intraoperative neuromonitoring and remote neurology services, enhancing surgical care and patient safety.
FAQ
What is the current stock price of ASSURE HLDGS (IONM)?
What is the market cap of ASSURE HLDGS (IONM)?
What is Assure Holdings Corp.?
What services does Assure Holdings provide?
In which types of surgeries does Assure Holdings offer its services?
Where is Assure Holdings based?
What recent achievements has Assure Holdings made?
Is Assure Holdings accredited?
How does Assure Holdings ensure quality during surgeries?
What is the mission of Assure Holdings?
How can I find more information about Assure Holdings?
What are the next steps for Assure Holdings regarding its Nasdaq listing?
